如何选择ARDS患者接受静脉-静脉体外膜氧合治疗
该文综述了严重ARDS患者接受静脉-静脉体外膜氧合(VV-ECMO)的患者选择问题,指出尽管ECMO技术安全性提高且更普及,但选择哪些患者启动ECMO仍具挑战性;现有临床与实验室标志物及风险评分并不完美,决策常基于机构指南和临床判断;强调应仅对有望康复或过渡至移植的患者提供ECMO,并讨论了无康复可能时撤除ECMO与姑息治疗的伦理困境。
要点
- ECMO用于严重ARDS以促进气体交换和更肺保护性通气,但患者选择至关重要。
- 现有标志物和风险评分不完美,决策常依赖机构指南与临床判断。
- 仅应对有合理康复机会或可桥接移植的患者提供ECMO。
核心结论
- 选择ARDS患者启动VV-ECMO仍具挑战性,现有标志物与风险评分不完美,决策常基于机构指南和临床判断。
- 应仅对有合理康复机会或桥接移植可能的患者提供ECMO,无康复或移植可能时可能需撤除ECMO并姑息治疗。
研究设计与样本
- 综述类文章,包含一例有争议的病例报告及关于ARDS患者ECMO选择文献的回顾。
主要发现
- 过去20年ECMO技术改进提高了安全性和可转运性,使其在全球该患者群体中更可及。
- 多种临床和实验室标志物及多个风险评分已被研究用于辅助决策,但仍不完美。
- 无康复或移植可能而接受ECMO的患者可能清醒且可互动,对患者、家庭和临床团队构成挑战。
临床怎么用
- 临床选择ARDS患者启动ECMO时,应综合机构指南与临床判断,并评估康复或桥接移植的可能性。
- 对无康复或移植可能的ECMO患者,需考虑撤除ECMO并转为姑息治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ARDS is a lethal form of acute respiratory failure, and because no specific treatments exist, supportive care remains the primary management strategy in these patients. Extracorporeal membrane oxygenation (ECMO) has emerged as an intervention in patients with severe ARDS to facilitate gas exchange and the delivery of more lung protective ventilation. Over the past 20 years, improvements in ECMO technology have increased its safety and transportability, making it far more available to this patient population globally. Deciding which patients with ARDS should be initiated on ECMO remains a challenging question. Numerous clinical and laboratory markers have been investigated, and multiple risk scores developed, to aid physicians in this decision-making process. However, they are still imperfect, and the choice is often based on institutional guidelines and the clinical impression of the treating physician. Given the potential risks and resource implications for this intervention, patient selection is critical and it is important to provide ECMO only to patients who have a reasonable chance for recovery or bridge to transplantation. In patients undergoing ECMO where there is no potential for recovery or transplant, the only option may be withdrawal of ECMO and palliation. These patients may be awake and interactive, which is often a very challenging scenario for patients, families, and the clinical team. In this article, we present a more controversial case and a review of the literature regarding the selection of patients with ARDS who should receive ECMO.
引用
- Bullen EC, Teijeiro-Paradis R, Fan E, et al. How I Select Which Patients With ARDS Should Be Treated With Venovenous Extracorporeal Membrane Oxygenation. Chest. 2020. PMID: 32330459. doi:10.1016/j.chest.2020.04.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。